EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study

Maria Gabriella Raimondo, Hashem Mohammadian, Simon Rauber, Stefano Alivernini, Vladyslav Fedorchenko, Aleix Rius Rigau, Mario Raphael Angeli, Filippo Fagni, Giulia Corte, Koray Tascilar, Hannah Labinsky, Alina M Ramming und 8 weitere

Annals of the Rheumatic Diseases · 2026-02 · 85 (2) · 285-296

DOI: 10.1016/j.ard.2025.08.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026-02. Verfasst von Maria Gabriella Raimondo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Universitaetsklinikum Erlangen, E…. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Interleukin-17, Enthesopathy, Tendons. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Forschungszentrum Jülich, Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg, Novartis Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Enthesitis, a hallmark of psoriatic arthritis (PsA), reflects the interplay between mechanical stress and immune dysregulation at tendon-bone interfaces. This study investigates the cellular and molecular responses in entheseal tissues following interleukin (IL)-17A inhibition in patients with active PsA. METHODS: In this prospective, interventional phase 4 trial, we enrolled 10 patients with enthesitis of the lateral epicondyle, performed entheseal biopsies, and analysed tissues by imaging mass cytometry (IMC) and spatial transcriptomics before and after treatment. RESULTS: Following 24 weeks of IL-17A inhibition, 9/10 patients of the cohort clinically responded to treatment as assessed by Disease Activity in Psoriatic Arthritis (DAPSA), Spondyloarthritis research consortium of canada (SPARCC) score, and power Doppler sonography. IMC analysis showed significant reductions of enthesitis-related immune cell populations, in particular IL-17-producing CD4, CD8, CD4neg/CD8neg T cells, granulocytes, and innate lymphoid cells type 3. Spatial transcriptomics revealed that CD200+DKK3+ fibroblasts and innate lymphoid cells type 2 expanded and formed an anti-inflammatory niche upon treatment. Notably, IL-17A inhibition led to decreased osteoblast differentiation markers, suggesting a potential mechanism to inhibit pathological bone formation. CONCLUSIONS: These findings underline the pivotal role of IL-17A in enthesitis, showing that IL-17A inhibition profoundly modulates the tissue microenvironment of entheses in PsA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticInterleukin-17EnthesopathyTendonsAntirheumatic AgentsHumansMaleFemaleMiddle AgedProspective StudiesAdultBiopsyAntibodies, Monoclonal, Humanized

Substanzen

Interleukin-17IL17A protein, humanAntibodies, Monoclonal, HumanizedAntirheumatic Agentssecukinumab

Autor:innen und Institutionen

  • Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Universitaetsklinikum Erlangen, Erlangen, Germany; Deutsches Zentrum Immuntherapie (DZI), Friedrich-Ale…
  • Immunology Research Core Facility, Gemelli Science and Technology Park, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Division of Rheumatology and Clinical Immunology- Fondazione Policlinico Univer…
  • Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Universitaetsklinikum Erlangen, Erlangen, Germany.
  • Institute of Radiology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany; Department of Radiology, Chobanian & Avedisian School of Medicine, Boston University,…
  • Institute of Functional and Clinical Anatomy, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.

Förderung

  • Forschungszentrum Jülich
  • Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
  • Novartis Pharma
  • European Federation of Pharmaceutical Industries and Associations
  • Horizon 2020 Framework Programme
  • European Research Council
  • Innovative Medicines Initiative
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Raimondo, M. G., Mohammadian, H., Rauber, S., Alivernini, S., Fedorchenko, V., Rigau, A. R., Angeli, M. R., Fagni, F., Corte, G., Tascilar, K., Labinsky, H., Ramming, A. M., Roemer, F., Rech, J., Braeuer, L., D'Agostino, M. A., Schett, G., Pachowsky, M., Kleyer, A., & Ramming, A. (2026). Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study. Annals of the Rheumatic Diseases, 85(2), 285-296. https://doi.org/10.1016/j.ard.2025.08.032

Vancouver

Raimondo MG, Mohammadian H, Rauber S, Alivernini S, Fedorchenko V, Rigau AR, et al. Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study. Annals of the Rheumatic Diseases. 2026;85(2):285-296. doi:10.1016/j.ard.2025.08.032

BibTeX
@article{Raimondo2026,
  author = {Raimondo, Maria Gabriella and Mohammadian, Hashem and Rauber, Simon and Alivernini, Stefano and Fedorchenko, Vladyslav and Rigau, Aleix Rius and Angeli, Mario Raphael and Fagni, Filippo and Corte, Giulia and Tascilar, Koray and Labinsky, Hannah and Ramming, Alina M and Roemer, Frank and Rech, Juergen and Braeuer, Lars and D'Agostino, Maria Antonietta and Schett, Georg and Pachowsky, Milena and Kleyer, Arnd and Ramming, Andreas},
  title = {Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {2},
  pages = {285--296},
  doi = {10.1016/j.ard.2025.08.032}
}
Kostenlos starten →